These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31636843)

  • 21. Pharmacovigilance Signals of the Opioid Epidemic over 10 Years: Data Mining Methods in the Analysis of Pharmacovigilance Datasets Collecting Adverse Drug Reactions (ADRs) Reported to EudraVigilance (EV) and the FDA Adverse Event Reporting System (FAERS).
    Chiappini S; Vickers-Smith R; Guirguis A; Corkery JM; Martinotti G; Harris DR; Schifano F
    Pharmaceuticals (Basel); 2022 May; 15(6):. PubMed ID: 35745593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Sex- and Gender-Based Analysis of Adverse Drug Reactions: A Scoping Review of Pharmacovigilance Databases.
    Brabete AC; Greaves L; Maximos M; Huber E; Li A; Lê ML
    Pharmaceuticals (Basel); 2022 Feb; 15(3):. PubMed ID: 35337096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A retrospective analysis of reporting of adverse drug reactions to oncology drugs: An experience from a national center of clinical excellence.
    Sharma PK; Misra AK; Gupta A; Singh S; Dhamija P; Pareek P
    Indian J Pharmacol; 2018; 50(5):273-278. PubMed ID: 30636831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How to promote adverse drug reaction reports using information systems - a systematic review and meta-analysis.
    Ribeiro-Vaz I; Silva AM; Costa Santos C; Cruz-Correia R
    BMC Med Inform Decis Mak; 2016 Mar; 16():27. PubMed ID: 26926375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Language does not come "in boxes": Assessing discrepancies between adverse drug reactions spontaneous reporting and MedDRA® codes in European Portuguese.
    Inácio P; Airaksinen M; Cavaco A
    Res Social Adm Pharm; 2015; 11(5):664-74. PubMed ID: 25596069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early identification of adverse drug reactions from search log data.
    White RW; Wang S; Pant A; Harpaz R; Shukla P; Sun W; DuMouchel W; Horvitz E
    J Biomed Inform; 2016 Feb; 59():42-8. PubMed ID: 26610385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal.
    Marques J; Ribeiro-Vaz I; Pereira AC; Polónia J
    Int J Pharm Pract; 2014 Aug; 22(4):275-82. PubMed ID: 24188533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Under-reporting of adverse drug reactions, a problem that also involves medicines subject to additional monitoring. Preliminary data from a single-center experience on novel oral anticoagulants].
    Patrignani A; Palmieri G; Ciampani N; Moretti V; Mariani A; Racca L
    G Ital Cardiol (Rome); 2018 Jan; 19(1):54-61. PubMed ID: 29451510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adverse reactions associated with immune checkpoint inhibitors and bevacizumab: A pharmacovigilance analysis.
    Gu T; Jiang A; Zhou C; Lin A; Cheng Q; Liu Z; Zhang J; Luo P
    Int J Cancer; 2023 Feb; 152(3):480-495. PubMed ID: 36274626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacovigilance for antiretroviral drugs in Africa: lessons from a study in Abidjan, Cote d'Ivoire.
    Jaquet A; Djima MM; Coffie P; Kacou HD; Eholie SP; Messou E; Minga A; Guehi C; Yavo JC; Bissagnene E; Dabis F; Ekouevi DK;
    Pharmacoepidemiol Drug Saf; 2011 Dec; 20(12):1303-10. PubMed ID: 21735508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Knowledge, attitude, practice and barriers towards pharmacovigilance and adverse drug reactions reporting among healthcare professionals in Turkey: a systematic review.
    Khan Z; Karatas Y; Martins MAP; Jamshed S; Rahman H
    Curr Med Res Opin; 2022 Jan; 38(1):145-154. PubMed ID: 34694167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of documentation of patient reported adverse drug reactions on both paper-based medication charts and electronic medication charts at a New Zealand hospital.
    Shen W; Wong B; Chin JY; Lee M; Coulter C; Braund R
    N Z Med J; 2016 Oct; 129(1444):90-96. PubMed ID: 27806032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Headache as an Adverse Reaction to the Use of Medication in the Elderly: A Pharmacovigilance Study.
    Monteiro C; Dias B; Vaz-Patto M
    Int J Environ Res Public Health; 2021 Mar; 18(5):. PubMed ID: 33799926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequency and Nature of Adverse Drug Reactions Due to Non-Prescription Drugs in Children: A Retrospective Analysis from the French Pharmacovigilance Database.
    Durrieu G; Maupiler M; Rousseau V; Chebane L; Montastruc F; Bondon-Guitton E; Montastruc JL
    Paediatr Drugs; 2018 Feb; 20(1):81-87. PubMed ID: 28766184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are non-serious adverse reactions to psychiatric drugs really non-serious?
    Pozzi M; Bertella S; Cattaneo D; Molteni M; Perrone V; Carnovale C; Antoniazzi S; Clementi E; Radice S
    J Child Adolesc Psychopharmacol; 2013 Aug; 23(6):394-400. PubMed ID: 23952186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improving drug safety: From adverse drug reaction knowledge discovery to clinical implementation.
    Tan Y; Hu Y; Liu X; Yin Z; Chen XW; Liu M
    Methods; 2016 Nov; 110():14-25. PubMed ID: 27485605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unknown adverse drug reactions from spontaneous reports in a hospital setting: characterization, follow-up, and contribution to the pharmacovigilance system.
    Filippi-Arriaga F; Aguilera C; Guillén E; Bellas L; Pérez E; Vendrell L; Agustí A; Cereza G
    Front Pharmacol; 2023; 14():1211786. PubMed ID: 37492089
    [No Abstract]   [Full Text] [Related]  

  • 38. Completeness and accuracy of adverse drug reaction documentation in electronic medical records at a tertiary care hospital in Australia.
    McLachlan G; Broomfield A; Elliott R
    Health Inf Manag; 2023 May; 52(2):108-111. PubMed ID: 34930047
    [No Abstract]   [Full Text] [Related]  

  • 39. Analysis of Reporting Adverse Drug Reactions in Paediatric Patients in a University Hospital in the Netherlands.
    Dittrich ATM; Draaisma JMT; van Puijenbroek EP; Loo DMWMT
    Paediatr Drugs; 2020 Aug; 22(4):425-432. PubMed ID: 32557243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complementing the US Food and Drug Administration Adverse Event Reporting System With Adverse Drug Reaction Reporting From Social Media: Comparative Analysis.
    Zhou Z; Hultgren KE
    JMIR Public Health Surveill; 2020 Sep; 6(3):e19266. PubMed ID: 32996889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.